Publications

Recent Publications from Photonet Network Members

Joanna Campbell, Safe and effective use of phototherapy and photochemotherapy in the treatment of psoriasis. Br J Dermatol. 2020; 29: 547-52

Yule S, Sanyal S, Ibbotson S, Moseley H, Dawe RS. Self-administration of hospital-based narrowband ultraviolet B (TL-01) phototherapy: a feasibility study in an outpatient setting. Br J Dermatol. 2013;169:464-8

Sivaramakrishnan M, Woods J, Dawe, R. Narrowband UVB phototherapy in erthropoietic protoporphyria: case series. Br J Dermatol. DOI: 10.1111/bjd.12714

Milliken SVI, Wassall H, Lewis BJ, Logie J, Barker RN, Macdonald H, Vickers MA, Ormerod AD. Effects of ultraviolet light on human serum 25-hydroxyvitamin D and systemic immune funtion. J Allergy Clin. 2012; 129: 1554-1561

Berroeta L, Man I, Dawe RS, Ferguson J, Ibbotson SH. Randomized Double-blind Comparative Study of 8-Methoxypsoralen Bath Plus UV-A Treatment Regimens. Actas Dermosifiliogr 2010; 101: 729-30

Dawe RS. There are no safe exposure limits for phototherapy. Br J Dermatol 2010; 163: 209-10.

Dawe RS. Using ‘number needed to treat’ to express the magnitudes of benefit of ultraviolet B phototherapy and of antitumour necrosis factor-alpha therapies for psoriasis. Br J Dermatol 2010; 162: 456-7.

Dawe RS, Cameron HM, Yule S, Ibbotson SH, Moseley HH, Ferguson J. A randomized comparison of methods of selecting narrowband UV-B starting dose to treat chronic psoriasis. Arch Dermatol 2011; 147: 168-74.

Shareef M, Dawe R. Bath psoralen plus ultraviolet A for hidradenitis suppurativa_a review of 13 patients. Br J Dermatol 2011; 164: 895-6.

Smith G, Weidlich S, Dawe RS, Ibbotson SH. Glutathione S-transferase M1 (GSTM1) genotype but not GSTT1 or MC1R genotype influences erythemal sensitivity to narrow band (TL-01) UVB phototherapy. Pharmacogenet Genomics 2011; 21: 217-24.

Moseley, H., Allan, D., Amatiello, H., Coleman, A., du Peloux Menagé, H., Edwards, C., Exton, L., Ferguson, J., Garibaldinos, T., Martin, C. and Mohd Mustapa, M. (2015), Guidelines on the measurement of ultraviolet radiation levels in ultraviolet phototherapy: report issued by the British Association of Dermatologists and British Photodermatology Group 2015. Br J Dermatol, 173: 333-350. 

Goulden, V., Ling, T.C., Babakinejad, P., Dawe, R., Eadie, E., Fassihi, H., Fityan, A., Garibaldinos, T., Ibbotson, S.H., Novakovic, L., Rush, E., Weatherhead, S.C., Whitehouse, H., Hashme, M., Mohd Mustapa, M.F., Exton, L.S. and (2022), British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022*. Br J Dermatol, 187: 295-308. 

Ling, T., Clayton, T., Crawley, J., Exton, L., Goulden, V., Ibbotson, S., McKenna, K., Mohd Mustapa, M., Rhodes, L., Sarkany, R. and Dawe, R. (2016), British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen–ultraviolet A therapy 2015. Br J Dermatol, 174: 24-55.

Eadie, E., Gallacher, M., Gorczynski, A., Smith, L. and Dawe, R. Response to Decline in use of phototherapy in France from 2010 to 2019. British Journal of Dermatology. 2021;185(4):871-872.

Barnard, I.R.M., Eadie, E., McMillan, L., Moseley, H., Brown, C.T.A., Wood, K., Dawe, R. Could psoralen plus ultraviolet A1 (“PUVA1”) work? Depth penetration achieved by phototherapy lamps. British Journal of Dermatology. 2020;182(3):813-814. 

Britton, J., Eadie, E. and Turner, D. An investigation of different types of eyewear and face shields in protecting patients and operators from the harmful effects of ultraviolet radiation. Photodermatology, Photoimmunology & Photomedicine. 2019;35(4):246-254. 

Eadie, E., Ibbotson, S. and Dawe, R. (2018), Irradiance, as well as body site and timing of readings, is important in determining ultraviolet A minimal erythema dose. Br J Dermatol, 178: 297-298. 

Eadie, E., Valentine, R., Thompson, G., Campbell, K., Moseley, H. Transmitted Irradiance Not As Expected in Enclosed Handheld Minimal Erythema Dose (MED) Device. Photodermatology, Photoimmunology and Photomedicine. 2016; 32(5-6):304-306. 

Kerr, A.C., Ferguson, J., Attili, S.K., Beattie, P.E., Coleman, A.J., Dawe, R.S., Eberlein, B., Goulden, V., Ibbotson, S.H., Menage, H.d.P., Moseley, H., Novakovic, L., Walker, S.L., Woods, J.A., Young, A.R. and Sarkany, R.P.E. (2012), Ultraviolet A1 phototherapy: a British Photodermatology Group workshop report. Clinical and Experimental Dermatology, 37: 219-226.

Boswell, K. et al. Narrowband ultraviolet B treatment for psoriasis is highly economical and causes significant savings in cost for topical treatments. British Journal of Dermatology. 2018;179(5):1148-1156.

Foerster, J. et al. Narrowband UVB treatment is highly effective and causes a strong reduction in the use of steroid and other creams in psoriasis patients in clinical practice. PLoS ONE. 2017;12(8):e0181813

Foerster, J. and R. Dawe. Phototherapy achieves significant cost savings by the delay of drug-based treatment in psoriasis. Photodermatology, Photoimmunology and Photomedicine. 2020;36(2):90-96

Musters AH, Mashayekhi S, Harvey J, Axon E, Lax SJ, Flohr C, Drucker AM, Gerbens L, Ferguson J, Ibbotson S, Dawe RS, Garritsen F, Brouwer M, Limpens J, Prescott LE, Boyle RJ, Spuls PI. Phototherapy for atopic eczema. Cochrane Database of Systematic Reviews 2021, Issue 10. Art. No.: CD013870.

Choi JY, Owusu-Ayim M, Dawe R, Ibbotson S, Fleming C, Foerster J. Narrowband ultraviolet B phototherapy is associated with a reduction in topical corticosteroid and clinical improvement in atopic dermatitis: a historical inception cohort study. Clinical and Experimental Dermatology. 2021; 46: 1067-74

Butt S, Dawe R, Blair R, Ibbotson S. A new approach to Actinic Folliculitis: prophylactic narrowband UVB phototherapy.  Clinical Experimental Dermatology 2021; 46: 675-679

Bedair KF, Dawe RS. A retrospective review of factors associated with response to phototherapy and PUVA for atopic eczema. Photodermatology, Photoimmunology and Photomedicine 2020; 37: 153-156

Bedair K, Elhaded A, Hamad S, Ferguson J, Dawe RS. No association between whole-body ultraviolet A1 phototherapy and skin cancers in humans: A cancer registry linkage study. British Journal of Dermatology 2020; 183: 586-587

Naasan H, Dawe RS, Ibbotson SH. Efficacy of localized hand and foot phototherapy: a review of patients treated in a teaching hospital setting.  Clinical and Experimental Dermatology 2019; 44: 356-358

Harrop G, Dawe RS, Ibbotson S.  Are photosensitising medications associated with increased risk of important erythemal reactions during UVB phototherapy?  British Journal of Dermatology 2018; 179: 1184-1185